OTC:BIXT | Free Cash Flow | BIOXYTRAN, INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$238,610.00
2025-12-31-$236,971.00
2025-03-31-$167,323.00
2024-12-31-$127,937.00
2024-03-31-$109,567.00
2023-12-31-$92,626.00
2023-03-31-$186,889.00
2022-12-31-$156,693.00
2022-03-31-$691,411.00
2021-12-31-$143,659.00
2021-03-31-$391,100.00
2020-12-31-$890,831.00
2020-03-31-$156,789.00
2019-12-31-$185,598.00
2019-03-31-$139,730.00
2018-12-31-$188,625.00
2018-03-31-$80.00
2017-12-31-$30,874.00
2017-03-31-$8,042.00
2016-12-31-$7,681.00
2016-03-31-$19,033.00
2015-12-31-$13,166.00
2015-03-31-$3,438.00
2014-12-31-$11,408.00
2014-03-31$38,949.00
2013-12-31$4,275.00
2013-03-31$6,109.00
2012-12-31-$5,505.00
2012-03-31-$13,008.00
2011-12-31-$189,389.00
2011-03-31-$54,552.00
2010-12-31-$12,755.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$526,455.00
2024-12-31-$381,316.00
2023-12-31-$775,375.00
2022-12-31-$1.81M
2021-12-31-$1.7M
2020-12-31-$1.1M
2019-12-31-$431,033.00
2018-12-31-$185,904.00
2017-12-31-$18,518.00
2016-12-31-$42,389.00
2015-12-31-$2,687.00
2014-12-31-$16,321.00
2013-12-31$9,273.00
2012-12-31-$63,680.00
2011-12-31-$398,762.00
2010-12-31-$75,804.00